NO20042089L - Fremgangsmate for a screene legemiddel som virker pa cellevegg - Google Patents

Fremgangsmate for a screene legemiddel som virker pa cellevegg

Info

Publication number
NO20042089L
NO20042089L NO20042089A NO20042089A NO20042089L NO 20042089 L NO20042089 L NO 20042089L NO 20042089 A NO20042089 A NO 20042089A NO 20042089 A NO20042089 A NO 20042089A NO 20042089 L NO20042089 L NO 20042089L
Authority
NO
Norway
Prior art keywords
cell wall
reporter protein
targeting site
acts
procedure
Prior art date
Application number
NO20042089A
Other languages
English (en)
Inventor
Akihiro Kitamura
Ryohei Nakajima
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20042089L publication Critical patent/NO20042089L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20042089A 2001-10-22 2004-05-21 Fremgangsmate for a screene legemiddel som virker pa cellevegg NO20042089L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001323293 2001-10-22
PCT/JP2002/010932 WO2003035898A1 (fr) 2001-10-22 2002-10-22 Methode de criblage d'un medicament agissant sur la paroi cellulaire

Publications (1)

Publication Number Publication Date
NO20042089L true NO20042089L (no) 2004-05-21

Family

ID=19140207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042089A NO20042089L (no) 2001-10-22 2004-05-21 Fremgangsmate for a screene legemiddel som virker pa cellevegg

Country Status (9)

Country Link
US (1) US7459268B2 (no)
EP (1) EP1445327B1 (no)
JP (1) JP4204471B2 (no)
AT (1) ATE370243T1 (no)
CA (1) CA2464396A1 (no)
DE (1) DE60221883T2 (no)
ES (1) ES2294172T3 (no)
NO (1) NO20042089L (no)
WO (1) WO2003035898A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4204471B2 (ja) 2001-10-22 2009-01-07 第一三共株式会社 細胞壁作用性薬剤のスクリーニング方法
CN1936006B (zh) * 2005-09-22 2012-05-30 三得利控股株式会社 编码细胞壁甘露糖蛋白的基因及其用途
TWI428091B (zh) * 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
WO2020018888A1 (en) 2018-07-20 2020-01-23 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
CN115094142B (zh) * 2022-07-19 2024-05-28 中国医学科学院肿瘤医院 用于诊断肺肠型腺癌的甲基化标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6027910A (en) 1992-07-08 2000-02-22 Unilever Patent Holdings B.V. Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein
JPH0956384A (ja) * 1995-08-25 1997-03-04 Toray Ind Inc 細胞の標識方法
EP0916726A1 (en) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Attaching substances to micro-organisms
AU4566699A (en) 1998-06-25 2000-01-10 Collaborative Group, Ltd., The Beta(1,6)-glucan synthesis and cell wall assembly assay
JP2000102387A (ja) 1998-09-29 2000-04-11 Daicel Chem Ind Ltd 発光蛋白質発現組換えベクター、及びこの組換えベクターにより形質転換された酵母
EP1283261B1 (en) 2000-05-01 2008-08-06 Daiichi Sankyo Company, Limited Method of screening drug acting on cell wall
JP4204471B2 (ja) 2001-10-22 2009-01-07 第一三共株式会社 細胞壁作用性薬剤のスクリーニング方法

Also Published As

Publication number Publication date
EP1445327B1 (en) 2007-08-15
CA2464396A1 (en) 2003-05-01
JPWO2003035898A1 (ja) 2005-02-10
ES2294172T3 (es) 2008-04-01
WO2003035898A1 (fr) 2003-05-01
US20050069965A1 (en) 2005-03-31
DE60221883D1 (de) 2007-09-27
EP1445327A1 (en) 2004-08-11
EP1445327A4 (en) 2005-09-14
DE60221883T2 (de) 2008-04-30
US7459268B2 (en) 2008-12-02
ATE370243T1 (de) 2007-09-15
JP4204471B2 (ja) 2009-01-07

Similar Documents

Publication Publication Date Title
HK1094231A1 (en) Prebiotic effect analysis
DE60232323D1 (de) Verbessertes verfahren zum nachweis von atp
BR0208597A (pt) Meio de detecção de staphylococcus aureus e/ou estafilococos com coagulose positiva e método de identificação de bactéria (s) da espécie staphylococcus aureus em uma amostra
ATE316147T1 (de) Enzymsensor
BR0115054A (pt) Métodos e dispositivos para analisar produtos agrìcolas
WO2007120699A3 (en) Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds & other chemicals
ATE330032T1 (de) Verfahren zur erhaltung der dns-integrität
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE335852T1 (de) Happier mapping
GB2410798A (en) Methods detecting, characterising and monitoring hydrocarbon reservoirs
NO20055025D0 (no) Multiplex screening for lysosomale lagringsforstyrrelser (LSD)
WO2004094992A3 (en) Methods for analysis of biological dataset profiles
ATE503021T1 (de) Verfahren zum nachweis von endoglykosidase aktivität
NO20042089L (no) Fremgangsmate for a screene legemiddel som virker pa cellevegg
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
DE60334923D1 (de) Tät
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
DE602006019628D1 (de) Verfahren zum testen von enzymaktivität in einer histologischen probe
WO2007074469A3 (en) Method and system for compiling a source code
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
BRPI0413897A (pt) método para titulação in vitro de um atnc e sua aplicação a um método de avaliação e/ou de controle de um processo para obtenção de um produto biológico
ATE326982T1 (de) Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit copolymeren
NO20025217D0 (no) FremgangsmÕte for screening av legemiddel som virker pÕ cellevegg
WO2005035785A3 (fr) Methode de detection rapide de micro-organismes sur puces a adn
NO20082394L (no) Polypeptidmarkor for diagnostikk og vurdering av vaskulaere sykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application